Anti-CD103 neutralizing monoclonal antibodies compromise the cytotoxic function of CD103+ tumor-infiltrating lymphocytes (TILs) to kill autologous tumor cells (Djenidi et al., 2015). Here, ITGAE is linked to neoplasm.